荣昌生物(09995)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

09995 荣昌生物

未开盘 12-23 16:08:41

14.800

+0.040

+0.27%

最高14.980	最低14.660	成交量52.99万
今开14.960	昨收14.760	日振幅2.17%
总市值80.56亿	流通市值28.12亿	总股本5.44亿
成交额784.24万	换手率0.28%	流通股本1.90亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"09995","market":"HK","secType":"STK","nameCN":"荣昌生物","latestPrice":14.8,"timestamp":1734941321017,"preClose":14.76,"halted":0,"volume":529900,"delay":0,"floatShares":190000000,"shares":544332083,"eps":-2.9774137,"marketStatus":"未开盘","marketStatusCode":0,"change":0.04,"latestTime":"12-23 16:08:41","open":14.96,"high":14.98,"low":14.66,"amount":7842410,"amplitude":0.02168,"askPrice":14.82,"askSize":3500,"bidPrice":14.8,"bidSize":8500,"shortable":3,"etf":0,"ttmEps":-3.0628506529540207,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1735003800000},"adr":0,"listingDate":1604851200000,"adjPreClose":14.76,"openAndCloseTimeList":[[1734917400000,1734926400000],[1734930000000,1734940800000]],"volumeRatio":0.45912122860947796,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688331","market":"SH","secType":"STK","nameCN":"荣昌生物","latestPrice":31.96,"timestamp":1734937200000,"preClose":31.92,"halted":0,"volume":2380371,"delay":0,"premium":"-56.45"}},"requestUrl":"/m/hq/s/09995/tweets","defaultTab":"tweets","newsList":[{"id":"2493876868","title":"荣昌生物：2025年1月10日将召开2025年第一次临时股东大会","url":"https://stock-news.laohu8.com/highlight/detail?id=2493876868","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493876868?lang=zh_cn&edition=full","pubTime":"2024-12-23 21:38","pubTimestamp":1734961129,"startTime":"0","endTime":"0","summary":"证券日报网讯12月23日晚间，荣昌生物发布公告称，公司将于2025年1月10日召开2025年第一次临时股东大会。本次股东大会将审议《关于荣昌生物制药（烟台）股份有限公司董事会更换独立董事的议案》。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202412233276503819.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU2328871848.SGD","09995","BK1583","BK1574","LU1969619763.USD","BK1161"],"gpt_icon":0},{"id":"2493734122","title":"荣昌生物(09995)：黄国滨获提名为独立非执行董事候选人","url":"https://stock-news.laohu8.com/highlight/detail?id=2493734122","media":"智通财经网","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493734122?lang=zh_cn&edition=full","pubTime":"2024-12-23 17:57","pubTimestamp":1734947847,"startTime":"0","endTime":"0","summary":"荣昌生物(09995)发布公告，于2024年12月23日举行的董事会会议上，黄国滨...","market":"sg","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_24.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_24.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1228486.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["688331","BK1574","LU1969619763.USD","LU2328871848.SGD","BK0239","LU1064130708.USD","09995","BK1583","LU1064131003.USD","BK1161","LU2148510915.USD"],"gpt_icon":0},{"id":"2493734755","title":"荣昌生物将于1月10日召开股东大会，共审议1项议案","url":"https://stock-news.laohu8.com/highlight/detail?id=2493734755","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493734755?lang=zh_cn&edition=full","pubTime":"2024-12-23 17:24","pubTimestamp":1734945843,"startTime":"0","endTime":"0","summary":"金融界12月23日消息，荣昌生物发布公告，将于2025年1月10日召开第1次临时股东大会，网络投票同日进行。股权登记日为1月7日，当日收市后持有荣昌生物股票的投资者可以参与投票。会议地点：山东省烟台市经济技术开发区北京中路58号荣昌生物三期6134会议室。本次股东大会共计审计1项议案，具体如下：1、关于荣昌生物制药(烟台)股份有限公司董事会更换独立董事的议案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223172718ab8d9444&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223172718ab8d9444&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2328871848.SGD","09995","BK1583","BK1574","LU1969619763.USD","BK1161"],"gpt_icon":0},{"id":"2493700452","title":"《大行》招商证券国际：内地创新医药行业首选翰森(03692.HK)及荣昌(09995.HK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2493700452","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493700452?lang=zh_cn&edition=full","pubTime":"2024-12-23 09:49","pubTimestamp":1734918540,"startTime":"0","endTime":"0","summary":"招商证券表示，在内地创新医药行业首选翰森及荣昌。当中，在翰森制药口服“GLP-1”实现小分子的第一次出海之后，预期该公司有望继续在双抗或ADC领域实现更多的BD落地；至于美股创新医药行业首选艾拉伦，料该公司2025财年收入增速将进一步提速。沽空资料截至 2024-12-20 16:25。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20220401114605030_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20220401114605030_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/analysis/china-hot-topic-content.aspx?id=NOW.1405837&catg=4&source=AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1589","BK0012","BK1191","BK1147","LU1969619763.USD","03692","BK0183","600999","BK0276","BK1161","09995","BK0010","BK1574","BK1583","06099","BK0028","BK0188","LU2328871848.SGD","BK1564"],"gpt_icon":0},{"id":"2493339409","title":"荣昌生物（688331）12月20日主力资金净卖出61.89万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2493339409","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493339409?lang=zh_cn&edition=full","pubTime":"2024-12-21 08:22","pubTimestamp":1734740561,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年12月20日收盘，荣昌生物报收于31.92元，下跌2.83%，换手率2.06%，成交量3.33万手，成交额1.08亿元。近5日资金流向一览见下表：荣昌生物融资融券信息显示，融资方面，当日融资买入864.05万元，融资偿还621.96万元，融资净买入242.09万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024122100011250.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1583","LU2148510915.USD","688331","LU2328871848.SGD","BK1574","LU1064130708.USD","LU1064131003.USD","BK1161","09995","LU1969619763.USD","BK0239"],"gpt_icon":0},{"id":"2492193394","title":"南向资金12月18日净买入荣昌生物40.40万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2492193394","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492193394?lang=zh_cn&edition=full","pubTime":"2024-12-19 09:30","pubTimestamp":1734571825,"startTime":"0","endTime":"0","summary":"12月18日, 南向资金增持荣昌生物40.40万股，连续3日增持。截止当日收盘，港股通共持有荣昌生物6907.72万股，占流通股36.42%。港股通增持金额前五个股分别为中国移动、工商银行、建设银行、中国海洋石油、中国平安。荣昌生物近5个交易日下跌8.36%，港股通累计增持39.60万股；近20个交易日下跌14.13%，港股通累计增持270.66万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219093824a1f9e22c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219093824a1f9e22c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2328871848.SGD","09995","688331","BK1583","BK1161","BK1574","LU1969619763.USD"],"gpt_icon":0},{"id":"2490773318","title":"12月12日荣昌生物发生1笔大宗交易 成交金额649.19万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490773318","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490773318?lang=zh_cn&edition=full","pubTime":"2024-12-12 17:20","pubTimestamp":1733995225,"startTime":"0","endTime":"0","summary":"证券之星消息，12月12日荣昌生物发生大宗交易，交易数据如下：大宗交易成交价格35.89元，成交18.09万股，成交金额649.19万元，买方营业部为中信证券股份有限公司深圳深南中路中信大厦证券营业部，卖方营业部为国泰君安证券股份有限公司总部。近三个月该股共发生1笔大宗交易，合计成交1809.0手。截至2024年12月12日收盘，荣昌生物报收于35.89元，上涨2.48%，换手率1.97%，成交量3.19万手，成交额1.14亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121200027965.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09995","BK1161","LU2148510915.USD","BK0239","LU1064131003.USD","LU2328871848.SGD","688331","LU1064130708.USD","LU1969619763.USD","BK1574","BK1583"],"gpt_icon":0},{"id":"2490095729","title":"荣昌生物：12月10日召开业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2490095729","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490095729?lang=zh_cn&edition=full","pubTime":"2024-12-10 19:03","pubTimestamp":1733828632,"startTime":"0","endTime":"0","summary":"证券之星消息，2024年12月10日荣昌生物发布公告称公司于2024年12月10日召开业绩说明会。荣昌生物2024年三季报显示，公司主营收入12.09亿元，同比上升57.1%；归母净利润-10.71亿元，同比下降3.96%；扣非净利润-10.97亿元，同比下降3.45%；其中2024年第三季度，公司单季度主营收入4.67亿元，同比上升34.6%；单季度归母净利润-2.91亿元，同比上升11.08%；单季度扣非净利润-3.04亿元，同比上升8.81%；负债率58.54%，投资收益124.19万元，财务费用4949.75万元，毛利率79.75%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121000036097.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1583","LU2148510915.USD","688331","LU2328871848.SGD","BK1574","LU1064130708.USD","LU1064131003.USD","BK1161","09995","LU1969619763.USD","BK0239"],"gpt_icon":0},{"id":"2489499914","title":"荣昌生物（688331）12月5日主力资金净买入417.22万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489499914","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489499914?lang=zh_cn&edition=full","pubTime":"2024-12-06 08:25","pubTimestamp":1733444753,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年12月5日收盘，荣昌生物报收于36.68元，下跌1.27%，换手率1.96%，成交量3.17万手，成交额1.17亿元。近5日资金流向一览见下表：荣昌生物融资融券信息显示，融资方面，当日融资买入802.56万元，融资偿还469.4万元，融资净买入333.16万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024120600007432.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1064130708.USD","LU2328871848.SGD","BK0239","09995","688331","BK1583","BK1161","LU1064131003.USD","LU2148510915.USD","BK1574","LU1969619763.USD"],"gpt_icon":0},{"id":"2489178357","title":"荣昌生物（688331）12月4日主力资金净买入236.99万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489178357","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489178357?lang=zh_cn&edition=full","pubTime":"2024-12-05 08:20","pubTimestamp":1733358044,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年12月4日收盘，荣昌生物报收于37.15元，下跌6.02%，换手率2.67%，成交量4.33万手，成交额1.64亿元。近5日资金流向一览见下表：荣昌生物融资融券信息显示，融资方面，当日融资买入1378.42万元，融资偿还1010.24万元，融资净买入368.18万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024120500007027.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2148510915.USD","LU1064130708.USD","LU2328871848.SGD","BK1583","LU1064131003.USD","BK0239","09995","BK1161","BK1574","688331","LU1969619763.USD"],"gpt_icon":0},{"id":"2488156117","title":"12月4日荣昌生物跌6.02%，中银创新医疗混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2488156117","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488156117?lang=zh_cn&edition=full","pubTime":"2024-12-04 16:08","pubTimestamp":1733299721,"startTime":"0","endTime":"0","summary":"证券之星消息，12月4日荣昌生物跌6.02%，收盘报37.15元，换手率2.67%，成交量4.33万手，成交额1.64亿元。根据2024基金Q3季报公募基金重仓股数据，重仓该股的公募基金共21家，其中持有数量最多的公募基金为中银创新医疗混合A。中银创新医疗混合A目前规模为21.23亿元，最新净值1.3839，较上一交易日上涨0.39%，近一年下跌5.35%。中银创新医疗混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024120400027503.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","LU1969619763.USD","09995","002173","LU1064130708.USD","BK1161","BK0239","LU2328871848.SGD","688331","BK1574","LU2148510915.USD","BK0096","BK1583","BK0236","BK0114","LU1064131003.USD"],"gpt_icon":0},{"id":"2488134068","title":"股市播报｜A股全线下跌，创业板指跌1.34%，近4400只个股下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2488134068","media":"腾讯财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488134068?lang=zh_cn&edition=full","pubTime":"2024-12-04 14:39","pubTimestamp":1733294367,"startTime":"0","endTime":"0","summary":"09:00 富时中国A50指数期货开跌0.2%      富时中国A50指数期货在上一交易日夜盘收跌0.16%的基础上低开，现跌0.2%。      ","market":"us","thumbnail":"https://inews.gtimg.com/news_ls/OS2OZ4kVzxwLdMtjz_jdA3In4qTAeMU9kR0cj2d-trFY4AA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/news_ls/OS2OZ4kVzxwLdMtjz_jdA3In4qTAeMU9kR0cj2d-trFY4AA_294195/0"],"rights":{"source":"tencent_tech","url":"https://view.inews.qq.com/a/20241204A01MIJ00","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://view.inews.qq.com/a/20241204A01MIJ00","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["09926","LU0823426480.USD","LU0572944931.SGD","02833","EDU","BK1526","09995","BK4505","LU0048580855.USD","LU0052750758.USD","BK4510","BK1163","LU0370786039.SGD","LU1720050803.USD","HSTECH","LU0348784397.USD","LU0588546209.SGD","IE00B5MMRT66.SGD","HHImain","LU1794554557.SGD","LU0502904849.HKD","HSI","LU0307460666.USD","YANG","01347","513600","MCHmain","LU0708995583.HKD","LU2242644610.SGD","BK1109","BK1589","IE0034224299.USD","LU2488822045.USD","SG9999006597.SGD","02105","09901","09660","BK1519","BK4506","LU0039217434.USD","01541","BK1583","IE00BPRC5H50.USD","LU0348783233.USD","LU1969619763.USD","HSCEI","LU0320764599.SGD","BK1574"],"gpt_icon":1},{"id":"2488242188","title":"荣昌生物(09995)下跌5.05%，报18.04元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2488242188","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488242188?lang=zh_cn&edition=full","pubTime":"2024-12-04 09:48","pubTimestamp":1733276893,"startTime":"0","endTime":"0","summary":"12月4日，荣昌生物(09995)盘中下跌5.05%，截至09:48，报18.04元/股，成交496.33万元。荣昌生物制药(烟台)股份有限公司的主营业务是发现、开发、生产和商业化同类首创、同类最佳的生物药物，主要针对自身免疫、肿瘤、眼科等重大疾病领域。公司在中国和美国设有实验研究机构和办事处，已创制出一批具有重大临床价值的生物新药。截至2024年三季报，荣昌生物营业总收入12.09亿元、净利润-10.71亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/12/04094845987207.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU2148510915.USD","BK1574","LU1064130708.USD","09995","LU1064131003.USD","LU1969619763.USD","LU2328871848.SGD","688331","BK0239","BK1161","BK1583"],"gpt_icon":0},{"id":"2488007769","title":"荣昌生物盘中异动 早盘股价大跌5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488007769","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488007769?lang=zh_cn&edition=full","pubTime":"2024-12-04 09:48","pubTimestamp":1733276890,"startTime":"0","endTime":"0","summary":"2024年12月04日早盘09时48分，荣昌生物股票出现异动，股价快速跳水5.16%。截至发稿，该股报18.020港元/股，成交量27万股，换手率0.14%，振幅3.89%。机构评级方面，在所有20家参与评级的机构中，85%的券商给予买入建议，15%的券商给予持有建议，无券商给予卖出建议。荣昌生物股票所在的生物技术行业中，整体跌幅为0.37%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204094810abf43228&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204094810abf43228&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1969619763.USD","09995","BK1161","LU2328871848.SGD","BK1574","BK1583"],"gpt_icon":0},{"id":"2488938078","title":"荣昌生物（688331）12月2日主力资金净卖出1577.11万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488938078","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488938078?lang=zh_cn&edition=full","pubTime":"2024-12-03 08:17","pubTimestamp":1733185042,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年12月2日收盘，荣昌生物报收于37.68元，上涨5.02%，换手率3.43%，成交量5.56万手，成交额2.06亿元。近5日资金流向一览见下表：荣昌生物融资融券信息显示，融资方面，当日融资买入1025.04万元，融资偿还1228.72万元，融资净偿还203.68万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024120300008000.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1969619763.USD","LU1064130708.USD","BK1574","BK0239","09995","LU2328871848.SGD","688331","BK1583","LU1064131003.USD","LU2148510915.USD","BK1161"],"gpt_icon":0},{"id":"2488262130","title":"荣昌生物：业绩说明会定于12月10日举行","url":"https://stock-news.laohu8.com/highlight/detail?id=2488262130","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488262130?lang=zh_cn&edition=full","pubTime":"2024-12-02 17:44","pubTimestamp":1733132694,"startTime":"0","endTime":"0","summary":"每经AI快讯，荣昌生物12月2日晚间发布公告称，公司2024年第三季度业绩说明会定于2024年12月10日上午10:00-11:00，以上证路演中心网络互动的形式进行。出席本次业绩说明会的人员有：董事长王威东，总经理房健民，董事会秘书温庆凯，首席财务官兼联席公司秘书童少靖，独立董事陈云金。荣昌生物的董事长是王威东，男，65岁，学历背景为本科。每经头条（nbdtoutiao）——任务完不成，每周扣1000元！有银行客户经理吐槽“大家都等着降级”！有人一个季度绩效1万元，他说：工作压力很大(记者 蔡鼎)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202174500a265f35f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202174500a265f35f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","LU1969619763.USD","BK1161","09995","LU2328871848.SGD","688331","BK1583"],"gpt_icon":0},{"id":"2487123105","title":"荣昌生物（688331）11月29日主力资金净卖出154.34万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2487123105","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2487123105?lang=zh_cn&edition=full","pubTime":"2024-11-30 08:24","pubTimestamp":1732926285,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年11月29日收盘，荣昌生物报收于35.88元，下跌0.36%，换手率2.98%，成交量4.83万手，成交额1.74亿元。近5日资金流向一览见下表：荣昌生物融资融券信息显示，融资方面，当日融资买入884.41万元，融资偿还988.1万元，融资净偿还103.69万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024113000008244.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1064131003.USD","688331","LU1064130708.USD","BK1574","BK0239","LU2328871848.SGD","LU1969619763.USD","09995","BK1583","LU2148510915.USD","BK1161"],"gpt_icon":0},{"id":"2487560107","title":"荣昌生物：3季度末现金储备11.2亿，如何撑到公司盈利？","url":"https://stock-news.laohu8.com/highlight/detail?id=2487560107","media":"公司研究室","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2487560107?lang=zh_cn&edition=full","pubTime":"2024-11-29 12:45","pubTimestamp":1732855557,"startTime":"0","endTime":"0","summary":"出品/公司研究室上市公司组文/淮上月近日，科创板生物制药公司荣昌生物（688331.SH）发布了一份2024年10月30日-11月6日投资者关系活动记录表。记录表显示，参加活动的机构累计上百家。记录内容就两个：一是2024Q3 财务概况；二是2024Q3 核心管线开发进展。这些内容与荣昌生物对公司研究室沟通函的回复口径基本一致。不过，...","market":"us","thumbnail":"https://inews.gtimg.com/om_ls/OyTV7MHgrz_rvXMihni1EeB3rtBXk5UHmy8LhHQ9sAM04AA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/OyTV7MHgrz_rvXMihni1EeB3rtBXk5UHmy8LhHQ9sAM04AA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20241129A04A1W00","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20241129A04A1W00","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["BK1583","LU2328871848.SGD","09995","LU1969619763.USD","BK1161","BK1574"],"gpt_icon":0},{"id":"2487378659","title":"荣昌生物（688331）11月28日主力资金净卖出717.37万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2487378659","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2487378659?lang=zh_cn&edition=full","pubTime":"2024-11-29 08:20","pubTimestamp":1732839658,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年11月28日收盘，荣昌生物报收于36.01元，下跌2.78%，换手率2.87%，成交量4.65万手，成交额1.71亿元。近5日资金流向一览见下表：荣昌生物融资融券信息显示，融资方面，当日融资买入929.33万元，融资偿还1052.5万元，融资净偿还123.17万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112900005020.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688331","LU1969619763.USD","LU2328871848.SGD","09995","BK1583","LU1064130708.USD","LU2148510915.USD","LU1064131003.USD","BK0239","BK1161","BK1574"],"gpt_icon":0},{"id":"2486601351","title":"荣昌生物费用管控成效显著，集中资源加速重点管线推进（繁体版）","url":"https://stock-news.laohu8.com/highlight/detail?id=2486601351","media":"第一上海","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486601351?lang=zh_cn&edition=full","pubTime":"2024-11-28 13:13","pubTimestamp":1732770818,"startTime":"0","endTime":"0","summary":"公司Q3销售费用率49.9%，连续两个季度维持在50%以下。研发费用环比下降26.9%，费用率74.3%。截止9月30日，公司在手现金及现金等价物11.2亿元，贷款授信额度28亿元。BC伴肝转移适应症已递交上市申请并纳入优先审评，有望在2025年获批。研发控费集中资源，重点管线持续推进：在公司梳理临床管线后，重点管线也将获得更多资源以加速推进。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241128133032a25b85c0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241128133032a25b85c0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","LU2328871848.SGD","BK1574","BK1161","09995","LU1969619763.USD"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0875},{"period":"1month","weight":-0.1159},{"period":"3month","weight":0.2914},{"period":"6month","weight":-0.4415},{"period":"1year","weight":-0.5549},{"period":"ytd","weight":-0.6048}],"compareEarnings":[{"period":"1week","weight":0.0044},{"period":"1month","weight":0.034},{"period":"3month","weight":0.0464},{"period":"6month","weight":0.0991},{"period":"1year","weight":0.2168},{"period":"ytd","weight":0.1663}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"荣昌生物制药（烟台）股份有限公司是一家主要从事创新型生物药研发和制造的中国公司。该公司专注于抗体药物偶联物（ADC）、抗体融合蛋白、单克隆抗体及双特异性抗体等治疗性抗体药物的发现、开发与商业化。该公司的主要产品包括泰它西普（RC18）、维迪西妥单抗（RC48）和双靶点融合蛋白（RC28）。该公司的产品主要应用于治疗自身免疫疾病、肿瘤和眼科等重大疾病。该公司主要在国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.188174},{"month":2,"riseRate":0.75,"avgChangeRate":0.173193},{"month":3,"riseRate":0.25,"avgChangeRate":-0.108046},{"month":4,"riseRate":0.75,"avgChangeRate":-0.020996},{"month":5,"riseRate":0.25,"avgChangeRate":-0.095931},{"month":6,"riseRate":0.75,"avgChangeRate":0.127279},{"month":7,"riseRate":0.5,"avgChangeRate":-0.067258},{"month":8,"riseRate":0.25,"avgChangeRate":-0.07116},{"month":9,"riseRate":0.5,"avgChangeRate":0.075505},{"month":10,"riseRate":0.5,"avgChangeRate":0.092826},{"month":11,"riseRate":1,"avgChangeRate":0.04024},{"month":12,"riseRate":0.4,"avgChangeRate":-0.014578}],"exchange":"SEHK","name":"荣昌生物","nameEN":"REMEGEN"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"荣昌生物(09995)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供荣昌生物(09995)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"荣昌生物,09995,荣昌生物股票,荣昌生物股票老虎,荣昌生物股票老虎国际,荣昌生物行情,荣昌生物股票行情,荣昌生物股价,荣昌生物股市,荣昌生物股票价格,荣昌生物股票交易,荣昌生物股票购买,荣昌生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"荣昌生物(09995)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供荣昌生物(09995)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}